These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 2217009)

  • 1. Acanthosis nigricans in obese women with the polycystic ovary syndrome: disease spectrum not distinct entity.
    Conway GS; Jacobs HS
    Postgrad Med J; 1990 Jul; 66(777):536-8. PubMed ID: 2217009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of acanthosis nigricans with insulin resistance in patients with polycystic ovary syndrome.
    Panidis D; Skiadopoulos S; Rousso D; Ioannides D; Panidou E
    Br J Dermatol; 1995 Jun; 132(6):936-41. PubMed ID: 7662572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of obesity and hyperinsulinemia in the insulin resistance of obese subjects with the clinical triad of polycystic ovaries, hirsutism and acanthosis nigricans.
    Wajchenberg BL; Giannella-Neto D; Lerario AC; Marcondes JA; Ohnuma LY
    Horm Res; 1988; 29(1):7-13. PubMed ID: 3397043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin resistance and overweight-obese women with polycystic ovary syndrome.
    Bhattacharya SM
    Gynecol Endocrinol; 2010 May; 26(5):344-7. PubMed ID: 19903118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin resistance, acanthosis nigricans, and polycystic ovaries associated with a circulating inhibitor of postbinding insulin action.
    Harrison LC; Dean B; Peluso I; Clark S; Ward G
    J Clin Endocrinol Metab; 1985 May; 60(5):1047-52. PubMed ID: 3884647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of insulin resistance in obese women with and without acanthosis nigricans.
    Sadeghian G; Ziaie H; Amini M; Ali Nilfroushzadeh M
    J Dermatol; 2009 Apr; 36(4):209-12. PubMed ID: 19348659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance, and/or hyperinsulinemia.
    Dunaif A; Graf M; Mandeli J; Laumas V; Dobrjansky A
    J Clin Endocrinol Metab; 1987 Sep; 65(3):499-507. PubMed ID: 3305551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spectrum of endocrine abnormalities associated with acanthosis nigricans.
    Matsuoka LY; Wortsman J; Gavin JR; Goldman J
    Am J Med; 1987 Oct; 83(4):719-25. PubMed ID: 3674058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycosaminoglycan deposition in the acanthosis nigricans lesions of the polycystic ovary syndrome.
    Wortsman J; Matsuoka LY; Kupchella CE; Gavin JR; Dietrich JG
    Arch Intern Med; 1983 Jun; 143(6):1145-8. PubMed ID: 6344826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and metabolic features of polycystic ovary syndrome among Chinese adolescents.
    Li L; Chen X; He Z; Zhao X; Huang L; Yang D
    J Pediatr Adolesc Gynecol; 2012 Dec; 25(6):390-5. PubMed ID: 23089573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bimodal correlation between the circulating insulin level and the production rate of dehydroepiandrosterone: positive correlation in controls and negative correlation in the polycystic ovary syndrome with acanthosis nigricans.
    Farah MJ; Givens JR; Kitabchi AE
    J Clin Endocrinol Metab; 1990 Apr; 70(4):1075-81. PubMed ID: 2138630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome.
    Shi Y; Guo M; Yan J; Sun W; Zhang X; Geng L; Xu L; Chen Z
    Neuro Endocrinol Lett; 2007 Dec; 28(6):807-10. PubMed ID: 18063948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical features, hormonal profile, and metabolic abnormalities of obese women with obese polycystic ovary syndrome].
    Li X; Lin JF
    Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(46):3266-71. PubMed ID: 16409817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adiponectin levels in women with polycystic ovary syndrome and severe insulin resistance.
    Sepilian V; Nagamani M
    J Soc Gynecol Investig; 2005 Feb; 12(2):129-34. PubMed ID: 15695109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A syndrome of hyperandrogenism, insulin resistance, and acanthosis nigricans associated with polycystic ovary syndrome: clinical and laboratory features.
    Taketani Y; Mizuno M
    Horm Res; 1990; 33 Suppl 2():27-30. PubMed ID: 2095357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acanthosis nigricans in obese women with hyperandrogenism. Characterization of an insulin-resistant state distinct from the type A and B syndromes.
    Flier JS; Eastman RC; Minaker KL; Matteson D; Rowe JW
    Diabetes; 1985 Feb; 34(2):101-7. PubMed ID: 3881301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical, biochemical, and ovarian morphologic features in women with acanthosis nigricans and masculinization.
    Dunaif A; Hoffman AR; Scully RE; Flier JS; Longcope C; Levy LJ; Crowley WF
    Obstet Gynecol; 1985 Oct; 66(4):545-52. PubMed ID: 3900841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acromegaly with polycystic ovaries, hyperandrogenism, hirsutism, insulin resistance and acanthosis nigricans: a case report.
    Unal A; Sahin Y; Keleştimur F
    Endocr J; 1993 Apr; 40(2):207-11. PubMed ID: 7951506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of acanthosis nigricans in childhood obesity.
    Guran T; Turan S; Akcay T; Bereket A
    J Paediatr Child Health; 2008 Jun; 44(6):338-41. PubMed ID: 18476925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features.
    Morales AJ; Laughlin GA; Bützow T; Maheshwari H; Baumann G; Yen SS
    J Clin Endocrinol Metab; 1996 Aug; 81(8):2854-64. PubMed ID: 8768842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.